TY  - JOUR
AU  - Timäus, Charles
AU  - Meiser, Miriam
AU  - Bandelow, Borwin
AU  - Engel, Kirsten R
AU  - Paschke, Anne M
AU  - Wiltfang, Jens
AU  - Wedekind, Dirk
TI  - Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
JO  - BMC psychiatry
VL  - 19
IS  - 1
SN  - 1471-244X
CY  - Heidelberg
PB  - Springer
M1  - DZNE-2020-07982
SP  - 393
PY  - 2019
AB  - The purpose of this study was to assess the pharmacological treatment strategies of inpatients with borderline personality disorder between 2008 and 2012. Additionally, we compared pharmacotherapy during this period to a previous one (1996 to 2004).Charts of 87 patients with the main diagnosis of borderline personality disorder receiving inpatient treatment in the University Medical Center of Goettingen, Germany, between 2008 and 2012 were evaluated retrospectively. For each inpatient treatment, psychotropic drug therapy including admission and discharge medication was documented. We compared the prescription rates of the interval 2008-2012 with the interval 1996-2004.94
KW  - Adult
KW  - Anticonvulsants: therapeutic use
KW  - Antidepressive Agents: therapeutic use
KW  - Antimanic Agents: therapeutic use
KW  - Antipsychotic Agents: therapeutic use
KW  - Borderline Personality Disorder: drug therapy
KW  - Borderline Personality Disorder: epidemiology
KW  - Borderline Personality Disorder: psychology
KW  - Female
KW  - Germany: epidemiology
KW  - Hospitalization: trends
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Narcotic Antagonists: therapeutic use
KW  - Prevalence
KW  - Psychotropic Drugs: therapeutic use
KW  - Retrospective Studies
KW  - Time Factors
KW  - Young Adult
LB  - PUB:(DE-HGF)16
C6  - pmid:31830934
C2  - pmc:PMC6909459
DO  - DOI:10.1186/s12888-019-2377-z
UR  - https://pub.dzne.de/record/141658
ER  -